DiCE Molecules attracts $60m

DiCE Molecules, a biopharmaceutical company, has raised $60 million in Series C-1 financing.

DiCE Molecules, a biopharmaceutical company, has raised $60 million in Series C-1 financing. RA Capital Management and Sands Capital led the round.

Source: Press Release